Cigarette Smoking and Lung Cancer: Modeling Total Exposure and Intensity

Investigators typically analyze cigarette smoking using smoking duration and intensity (number of cigarettes smoked per day) as risk factors. However, odds ratios (OR) for categories of intensity either adjusted for, or jointly with, duration of smoking may be distorted by differences in total pack-years of exposure to cigarette smoke. To study effects of intensity, we apply a linear excess OR model to compare total exposure delivered at low intensity for a long period of time with an equal total exposure delivered at high intensity for a short period of time to data from a large case-control study of lung cancer. The excess OR per pack-year increases with intensity for subjects who smoke ≤20 cigarettes per day and decreases with intensity for subjects who smoke >20 cigarettes per day. The intensity patterns are homogeneous by histologic type of lung cancer, suggesting that observed differences in risks by histologic type are related to total smoking exposure or smoking duration and not smoking intensity. At lower smoking intensities, there is an “exposure enhancement” effect such that for equal total exposure, the excess OR per pack-year increases with intensity. At higher smoking intensities, there is a “reduced potency” or “wasted exposure” effect such that for equal total exposure, the excess OR per pack-year decreases with intensity (i.e., smoking at a lower intensity for longer duration is more deleterious than smoking at a higher intensity for shorter duration). (Cancer Epidemiol Biomarkers Prev 2006;15(3):517–23)

[1]  Q. Wei,et al.  Nucleotide excision repair as a marker for susceptibility to tobacco‐related cancers: A review of molecular epidemiological studies , 2005, Molecular carcinogenesis.

[2]  M. Spitz,et al.  The role of DNA repair capacity in susceptibility to lung cancer: A review , 1997, Cancer and Metastasis Reviews.

[3]  S. Hecht,et al.  Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  W. Lutz,et al.  Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. , 1998, Mutation research.

[5]  K. Anderson,et al.  Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  C. Jepson,et al.  Individual differences in nicotine intake per cigarette. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  D. Phillips Smoking-related DNA and protein adducts in human tissues. , 2002, Carcinogenesis.

[8]  J. Lewtas,et al.  Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. , 1997, Mutation research.

[9]  M. Law,et al.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. , 1997, British Journal of Cancer.

[10]  B Rachet,et al.  A flexible modeling approach to estimating the component effects of smoking behavior on lung cancer. , 2004, Journal of clinical epidemiology.

[11]  M. Kogevinas,et al.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. , 2000, Mutation research.

[12]  K. Hoffmann,et al.  A Comprehensive Index for the Modeling of Smoking History in Periodontal Research , 2004, Journal of dental research.

[13]  Hongbing Shen,et al.  Smoking, DNA repair capacity and risk of nonsmall cell lung cancer , 2003, International journal of cancer.

[14]  M. Spitz,et al.  Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. , 2000, Journal of the National Cancer Institute.

[15]  F. Berrino,et al.  Patterns of lung cancer risk according to type of cigarette smoked , 1984, International journal of cancer.

[16]  Paolo Vineis,et al.  Dose‐response relationship in tobacco‐related cancers of bladder and lung: A biochemical interpretation , 2004, International journal of cancer.

[17]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.

[18]  Christopher I Amos,et al.  Genetic susceptibility to lung cancer: the role of DNA damage and repair. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Michal Abrahamowicz,et al.  Modeling smoking history: a comparison of different approaches. , 2002, American journal of epidemiology.

[20]  D. Christiani,et al.  Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  M. Bergmann,et al.  Re: "Modeling smoking history: a comparison of different approaches". , 2003, American journal of epidemiology.

[22]  N. Weiss,et al.  Logistic regression analysis for more than one characteristic of exposure. , 1999, American journal of epidemiology.

[23]  Jolanta Lissowska,et al.  Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. , 2005, Journal of the National Cancer Institute.

[24]  P Vineis,et al.  Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. , 2000, Journal of the National Cancer Institute.

[25]  K. Berhane,et al.  Using splines to analyse latency in the Colorado Plateau uranium miners cohort. , 2001, Journal of epidemiology and biostatistics.

[26]  J. Lubin,et al.  Assessment of lung cancer risk factors by histologic category. , 1984, Journal of the National Cancer Institute.